These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35311705)

  • 1. Oscillatory Activity of the Hippocampus in Prodromal Alzheimer's Disease: A Source-Space Magnetoencephalography Study.
    Luppi JJ; Schoonhoven DN; van Nifterick AM; Gouw AA; Hillebrand A; Scheltens P; Stam CJ; de Haan W
    J Alzheimers Dis; 2022; 87(1):317-333. PubMed ID: 35311705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal Oscillatory Patterns During Working Memory Maintenance in Mild Cognitive Impairment and Subjective Cognitive Decline.
    Serrano N; López-Sanz D; Bruña R; Garcés P; Rodríguez-Rojo IC; Marcos A; Crespo DP; Maestú F
    Int J Neural Syst; 2020 Jan; 30(1):1950019. PubMed ID: 31522594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiscale brain network model links Alzheimer's disease-mediated neuronal hyperactivity to large-scale oscillatory slowing.
    van Nifterick AM; Gouw AA; van Kesteren RE; Scheltens P; Stam CJ; de Haan W
    Alzheimers Res Ther; 2022 Jul; 14(1):101. PubMed ID: 35879779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexity changes in preclinical Alzheimer's disease: An MEG study of subjective cognitive decline and mild cognitive impairment.
    Shumbayawonda E; López-Sanz D; Bruña R; Serrano N; Fernández A; Maestú F; Abasolo D
    Clin Neurophysiol; 2020 Feb; 131(2):437-445. PubMed ID: 31884374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slowing of Hippocampal Activity Correlates with Cognitive Decline in Early Onset Alzheimer's Disease. An MEG Study with Virtual Electrodes.
    Engels MM; Hillebrand A; van der Flier WM; Stam CJ; Scheltens P; van Straaten EC
    Front Hum Neurosci; 2016; 10():238. PubMed ID: 27242496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease.
    Nakamura A; Cuesta P; Fernández A; Arahata Y; Iwata K; Kuratsubo I; Bundo M; Hattori H; Sakurai T; Fukuda K; Washimi Y; Endo H; Takeda A; Diers K; Bajo R; Maestú F; Ito K; Kato T
    Brain; 2018 May; 141(5):1470-1485. PubMed ID: 29522156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal resting-state EEG in amyloid-positive patients along the Alzheimer's disease continuum: considerations for clinical trials.
    Scheijbeler EP; de Haan W; Stam CJ; Twisk JWR; Gouw AA
    Alzheimers Res Ther; 2023 Oct; 15(1):182. PubMed ID: 37858173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha band disruption in the AD-continuum starts in the Subjective Cognitive Decline stage: a MEG study.
    López-Sanz D; Bruña R; Garcés P; Camara C; Serrano N; Rodríguez-Rojo IC; Delgado ML; Montenegro M; López-Higes R; Yus M; Maestú F
    Sci Rep; 2016 Nov; 6():37685. PubMed ID: 27883082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    Meghdadi AH; Stevanović Karić M; McConnell M; Rupp G; Richard C; Hamilton J; Salat D; Berka C
    PLoS One; 2021; 16(2):e0244180. PubMed ID: 33544703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEG spectral analysis in subtypes of mild cognitive impairment.
    López ME; Cuesta P; Garcés P; Castellanos PN; Aurtenetxe S; Bajo R; Marcos A; Delgado ML; Montejo P; López-Pantoja JL; Maestú F; Fernandez A
    Age (Dordr); 2014 Jun; 36(3):9624. PubMed ID: 24532390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network Disruption in the Preclinical Stages of Alzheimer's Disease: From Subjective Cognitive Decline to Mild Cognitive Impairment.
    López-Sanz D; Garcés P; Álvarez B; Delgado-Losada ML; López-Higes R; Maestú F
    Int J Neural Syst; 2017 Dec; 27(8):1750041. PubMed ID: 28958179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological brain signatures for the classification of subjective cognitive decline: towards an individual detection in the preclinical stages of dementia.
    López-Sanz D; Bruña R; Delgado-Losada ML; López-Higes R; Marcos-Dolado A; Maestú F; Walter S
    Alzheimers Res Ther; 2019 Jun; 11(1):49. PubMed ID: 31151467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEG delta mapping along the healthy aging-Alzheimer's disease continuum: diagnostic implications.
    Fernández A; Turrero A; Zuluaga P; Gil-Gregorio P; del Pozo F; Maestu F; Moratti S
    J Alzheimers Dis; 2013; 35(3):495-507. PubMed ID: 23478303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEG Oscillatory Slowing in Cognitive Impairment is Associated with the Presence of Subjective Cognitive Decline.
    Bruña R; López-Sanz D; Maestú F; Cohen AD; Bagic A; Huppert T; Kim T; Roush RE; Snitz B; Becker JT
    Clin EEG Neurosci; 2023 Jan; 54(1):73-81. PubMed ID: 35188831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the fluctuations of dynamic resting-state electrophysiological functional connectivity: reduced neuronal coupling variability in mild cognitive impairment and dementia due to Alzheimer's disease.
    Núñez P; Poza J; Gómez C; Rodríguez-González V; Hillebrand A; Tola-Arribas MA; Cano M; Hornero R
    J Neural Eng; 2019 Sep; 16(5):056030. PubMed ID: 31112938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.